Korenberg Matthew E

Korenberg Matthew E is listed in filings as Director at Lifecore Biomedical, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Lifecore Biomedical, Inc. (LFCR), Palvella Therapeutics, Inc. (PVLA), and Ligand Pharmaceuticals Incorporated - Common Stock (LGND). The current snapshot covers public activity from Jul 2, 2024 to Jun 5, 2026. Reported amounts are shown as $3.4M to $79.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.